| Literature DB >> 29447924 |
Andrew Erickson1, Kevin Sandeman2, Kanerva Lahdensuo3, Stig Nordling4, Markku Kallajoki5, Heikki Seikkula6, Anna Bützow7, Hanna Vasarainen3, Peter J Boström6, Pekka Taimen5, Antti Rannikko3, Tuomas Mirtti8.
Abstract
Entities:
Keywords: Competing risk analysis; Gleason grade; Grade Group; Prostate cancer; Survival
Mesh:
Substances:
Year: 2018 PMID: 29447924 DOI: 10.1016/j.humpath.2018.01.027
Source DB: PubMed Journal: Hum Pathol ISSN: 0046-8177 Impact factor: 3.466